<?xml version="1.0" encoding="iso-8859-1"?>
<frameset>
<predicate lemma="lose">
<roleset id="lose.01" name="" wordnet="1, 8">
<roles>
  <role n="0" descr="entity losing something
"/>
  <role n="1" descr="thing lost
"/>
  <role n="2" descr="situation inducing thing lost
"/>
</roles>
<example src="MEDLINE" no="1">
<text>
A new transthyretin variant which lost an Sph I cleavage site within exon 3 has been characterized.

</text>
       <arg n="0">A new transthyretin variant
</arg>
       <arg n="1">an Sph I cleavage site within exon 3
</arg>
       <arg n="2">-
</arg>
<fdg>
1	A	a	det:&gt;4	@DN&gt; %&gt;N DET SG
2	new	new	attr:&gt;3	@A&gt; %&gt;N A ABS
3	transthyretin	transthyretin	attr:&gt;4	@A&gt; %&gt;N &lt;?&gt; N NOM SG
4	variant	variant	subj:&gt;15	@SUBJ %NH N NOM SG
5	which	which	subj:&gt;6	@SUBJ %NH &lt;Rel&gt; PRON WH NOM
6	lost	lose	mod:&gt;4	@+FMAINV %VA V PAST
7	an	an	det:&gt;8	@DN&gt; %&gt;N DET SG
8	Sph	sph	obj:&gt;6	@OBJ %NH &lt;?&gt; N NOM SG
9	I	i		@SUBJ %NH PRON PERS NOM SG1
10	cleavage	cleavage	attr:&gt;11	@A&gt; %&gt;N N NOM SG
11	site	site		@SUBJ %NH N NOM SG	@OBJ %NH N NOM SG
12	within	within	ha:&gt;6	@ADVL %EH PREP
13	exon	exon	attr:&gt;14	@A&gt; %&gt;N N NOM SG
14	3	3	pcomp:&gt;12	@&lt;P %NH NUM CARD
15	has	have	v-ch:&gt;16	@+FAUXV %AUX V PRES SG3
16	been	be	v-ch:&gt;17	@-FAUXV %AUX EN
17	characterized	characterize	main:&gt;0	@-FMAINV %VP EN
18	.     .
</fdg>
</example>
<example src="MEDLINE" no="2">
<text>
The mice did not lose weight during the treatment.

</text>
       <arg n="0">The mice
</arg>
       <arg n="1">weight
</arg>
       <arg n="2">during the treatment
</arg>
       <arg n="M-NEG">not
</arg>
<fdg>
     
1	The	the	det:&gt;2	@DN&gt; %&gt;N DET
2	mice	mouse	subj:&gt;3	@SUBJ %NH N NOM PL
3	did	do	v-ch:&gt;5	@+FAUXV %AUX V PAST
4	not	not	neg:&gt;3	@ADVL %EH NEG-PART
5	lose	lose	main:&gt;0	@-FMAINV %VA V INF
6	weight	weight	obj:&gt;5	@OBJ %NH N NOM SG
7	during	during	ha:&gt;5	@ADVL %EH PREP
8	the	the	det:&gt;9	@DN&gt; %&gt;N DET
9	treatment	treatment	pcomp:&gt;7	@&lt;P %NH N NOM SG
10	.     .
</fdg>
</example>
<example src="MEDLINE" no="3">
<text>
To this end, we made aggregation chimeras between Lc/+ mice, which lose all Purkinje cells postnatally, and +/+ control mice.

</text>
       <arg n="0">aggregation chimeras between Lc/+ mice 
</arg>
       <arg n="1">Purkinje cells 
</arg>
       <arg n="2">-
</arg>
<fdg>
1	To	to	cla:&gt;6	@ADVL %EH PREP
2	this	this	det:&gt;3	@DN&gt; %&gt;N DET DEM SG
3	end	end	pcomp:&gt;1	@&lt;P %NH N NOM SG
4	,	,
5	we	we	subj:&gt;6	@SUBJ %NH PRON PERS NOM PL1
6	made	make	main:&gt;0	@+FMAINV %VA V PAST
7	aggregation	aggregation	attr:&gt;8	@A&gt; %&gt;N N NOM SG
8	chimeras	chimera	obj:&gt;6	@OBJ %NH N NOM PL
9	between	between	ha:&gt;6	@ADVL %EH PREP
10	Lc	lc	pcomp:&gt;9	@&lt;P %NH ABBR NOM SG
11	/	/	
12	+	+	cc:&gt;10	@CC %CC CC
13	mice	mouse	cc:&gt;10	@&lt;P %NH N NOM PL
14	,	,
15	which	which	subj:&gt;16	@SUBJ %NH &lt;Rel&gt; PRON WH NOM
16	lose	lose	mod:&gt;13	@+FMAINV %VA V PRES
17	all	all	det:&gt;19	@DN&gt; %&gt;N DET
18	Purkinje	purkinje	attr:&gt;19	@A&gt; %&gt;N &lt;?&gt; N NOM SG
19	cells	cell	obj:&gt;16	@OBJ %NH N NOM PL
20	postnatally	postnatally	man:&gt;16	@ADVL %EH ADV
21	,	,
22	and	and		@CC %CC CC
23	+	+		@CC %CC CC
24	/	/	
25	+	+		@CC %CC CC
26	control	control	attr:&gt;27	@A&gt; %&gt;N N NOM SG
27	mice	mouse		@APP %NH N NOM PL	@&lt;P %NH N NOM PL
28	.     .
</fdg>
</example>
<example src="MEDLINE" no="4">
<text>
This study investigated whether informing obese individuals that they would lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations.

</text>
       <arg n="0">they
</arg>
       <arg n="1">modest amounts of weight
</arg>
       <arg n="2">-
</arg>
       <arg n="M-ADV">only
</arg>
<fdg>
1	This	this	det:&gt;2	@DN&gt; %&gt;N DET DEM SG
2	study	study	subj:&gt;3	@SUBJ %NH N NOM SG
3	investigated	investigate		@+FMAINV %VA V PAST
4	whether	whether		@CS %CS CS
5	informing	inform		@-FMAINV %VA ING
6	obese	obese	attr:&gt;7	@A&gt; %&gt;N A ABS
7	individuals	individual	dat:&gt;5	@I-OBJ %NH N NOM PL
8	that	that	pm:&gt;11	@CS %CS CS
9	they	they	subj:&gt;10	@SUBJ %NH PRON PERS NOM PL3
10	would	would	v-ch:&gt;11	@+FAUXV %AUX V AUXMOD
11	lose	lose	obj:&gt;5	@-FMAINV %VA V INF
12	only	only	meta:&gt;14	@ADVL %EH ADV
13	modest	modest	attr:&gt;14	@A&gt; %&gt;N A ABS
14	amounts	amount	obj:&gt;11	@OBJ %NH N NOM PL
15	of	of	mod:&gt;14	@&lt;NOM-OF %N&lt; PREP
16	weight	weight	pcomp:&gt;15	@&lt;P %NH N NOM SG
17	would	would	v-ch:&gt;18	@+FAUXV %AUX V AUXMOD
18	lead	lead		@-FMAINV %VA V INF
19	them	they	subj:&gt;21	@OBJ %NH PRON PERS ACC PL3
20	to	to	pm:&gt;21	@INFMARK&gt; %AUX INFMARK&gt;
21	adopt	adopt	obj:&gt;18	@-FMAINV %VA V INF
22	more	much	ad:&gt;23	@AD-A&gt; %E&gt; ADV CMP
23	realistic	realistic	attr:&gt;24	@A&gt; %&gt;N A ABS
24	weight	weight	attr:&gt;25	@A&gt; %&gt;N N NOM SG
25	loss	loss	attr:&gt;26	@A&gt; %&gt;N N NOM SG
26	expectations	expectation	obj:&gt;21	@OBJ %NH N NOM PL
27	.     .
</fdg>
</example>
<example src="MEDLINE" no="5">
<text>
No severe complications have been reported, and after the BIB removal, subjects are maintaining the obtained results with some of them continuing to lose weight.

</text>
       <arg n="0">some of them 
</arg>
       <arg n="1">weight
</arg>
       <arg n="2">-
</arg>
<fdg>
1	No	no	det:&gt;3	@DN&gt; %&gt;N DET
2	severe	severe	attr:&gt;3	@A&gt; %&gt;N A ABS
3	complications	complication	subj:&gt;4	@SUBJ %NH N NOM PL
4	have	have	v-ch:&gt;5	@+FAUXV %AUX V PRES
5	been	be	v-ch:&gt;6	@-FAUXV %AUX EN
6	reported	report	main:&gt;0	@-FMAINV %VP EN
7	,	,
8	and	and	cc:&gt;6	@CC %CC CC
9	after	after	cla:&gt;16	@ADVL %EH PREP
10	the	the	det:&gt;12	@DN&gt; %&gt;N DET
11	BIB	bib	attr:&gt;12	@A&gt; %&gt;N N NOM SG
12	removal	removal	pcomp:&gt;9	@&lt;P %NH N NOM SG
13	,	,
14	subjects	subject	subj:&gt;15	@SUBJ %NH N NOM PL
15	are	be	v-ch:&gt;16	@+FAUXV %AUX V PRES
16	maintaining	maintain	cc:&gt;6	@-FMAINV %VA ING
17	the	the	det:&gt;19	@DN&gt; %&gt;N DET
18	obtained	obtained	attr:&gt;19	@A&gt; %&gt;N A ABS
19	results	result	obj:&gt;16	@OBJ %NH N NOM PL
20	with	with	ha:&gt;16	@ADVL %EH PREP
21	some	some	pcomp:&gt;20	@&lt;P %NH PRON
22	of	of	mod:&gt;21	@&lt;NOM-OF %N&lt; PREP
23	them	they	pcomp:&gt;22	@&lt;P %NH PRON PERS ACC PL3
24	continuing	continue		@&lt;P-FMAINV %VA ING	@-FMAINV %VA ING
25	to	to	pm:&gt;26	@INFMARK&gt; %AUX INFMARK&gt;
26	lose	lose	obj:&gt;24	@-FMAINV %VA V INF
27	weight	weight	obj:&gt;26	@OBJ %NH N NOM SG
28	.     .
</fdg>
</example>
<example src="EMBO" no="1">
<text>
Stat3 is activated in v-Src or v-abl-transformed cells and, along other Stats, in acute T-cell leukemia cells that have lost IL-2 dependency (Migone et al., 1995; Yu et al., 1995).

</text>
       <arg n="0">other Stats, in acute T-cell leukemia cells
</arg>
       <arg n="1">IL-2 dependency
</arg>
       <arg n="2">-
</arg>
<fdg>
1	Stat3	stat3	subj:&gt;2	@SUBJ %NH N NOM SG
2	is	be	v-ch:&gt;3	@+FAUXV %AUX V PRES SG3
3	activated	activate	main:&gt;0	@-FMAINV %VP EN
4	in	in	loc:&gt;3	@ADVL %EH PREP
5	v-Src	v-src	pcomp:&gt;4	@&lt;P %NH &lt;?&gt; N NOM SG
6	-	-
7	or	or		@CC %CC CC
8	v-abl-transformed	v-abl-transformed	attr:&gt;9	@A&gt; %&gt;N &lt;?&gt; A ABS
9	cells	cell		@NH %NH N NOM PL	@SUBJ %NH N NOM PL	@OBJ %NH N NOM PL	@APP %NH N NOM PL	@&lt;P %NH N NOM PL
10	and	and		@CC %CC CC
11	,	,
12	along with	along with		@ADVL %EH PREP
13	other	other	det:&gt;14	@DN&gt; %&gt;N DET
14	Stats	stat	pcomp:&gt;12	@&lt;P %NH N NOM PL
15	,	,
16	in	in		@ADVL %EH PREP
17	acute	acute	attr:&gt;18	@A&gt; %&gt;N A ABS
18	T-cell	t-cell	attr:&gt;19	@A&gt; %&gt;N N NOM SG
19	leukemia	leukemia	attr:&gt;20	@A&gt; %&gt;N N NOM SG
20	cells	cell	mod:&gt;14	@APP %NH N NOM PL
21	that	that	subj:&gt;22	@SUBJ %NH &lt;Rel&gt; PRON
22	have	have	v-ch:&gt;23	@+FAUXV %AUX V PRES
23	lost	lose	mod:&gt;20	@-FMAINV %VA EN
24	IL-2	il-2	attr:&gt;25	@A&gt; %&gt;N ABBR NOM SG
25	dependency	dependency	obj:&gt;23	@OBJ %NH N NOM SG
26	(	(
27	Migone	migone	main:&gt;26	@APP %NH &lt;?&gt; N NOM SG
28	et	et	cc:&gt;27	@CC %CC CC
29	al.	al.	cc:&gt;27	@APP %NH ABBR NOM SG
30	,	,
31	1995	1995		@NH %NH NUM CARD	@SUBJ %NH NUM CARD	@OBJ %NH NUM CARD	@PCOMPL-O %NH NUM CARD	@&lt;P %NH NUM CARD	@&lt;NOM %N&lt; NUM CARD
32	;	;
33	Yu	yu	mod:&gt;31	@NH %NH N NOM SG
34	et	et	cc:&gt;33	@CC %CC CC
35	al.	al.	cc:&gt;33	@NH %NH ABBR NOM SG
36	,	,
37	1995	1995	cc:&gt;35	@NH %NH NUM CARD
38	)	)
39	.     .
</fdg>
</example>
<example src="EMBO" no="2">
<text>
These interactions would be lost with a separation of DNA-binding sites of }3 bp, as can occur for natural SRE sequences, while a smaller spacing would inhibit the simultaneous binding of both proteins.

</text>
       <arg n="0">-
</arg>
       <arg n="1">These interactions
</arg>
       <arg n="2">with a separation of DNA-binding sites of }3 bp
</arg>
<fdg>
1	These	this	det:&gt;2	@DN&gt; %&gt;N DET DEM PL
2	interactions	interaction	subj:&gt;3	@SUBJ %NH N NOM PL
3	would	would	v-ch:&gt;4	@+FAUXV %AUX V AUXMOD
4	be	be	v-ch:&gt;5	@-FAUXV %AUX V INF
5	lost	lose		@-FMAINV %VP EN
6	with	with	ha:&gt;5	@ADVL %EH PREP
7	a	a	det:&gt;8	@DN&gt; %&gt;N DET SG
8	separation	separation	pcomp:&gt;6	@&lt;P %NH N NOM SG
9	of	of	mod:&gt;8	@&lt;NOM-OF %N&lt; PREP
10	DNA-binding	dna-binding	attr:&gt;11	@A&gt; %&gt;N N NOM SG
11	sites	site	pcomp:&gt;9	@&lt;P %NH N NOM PL
12	of	of	mod:&gt;11	@&lt;NOM-OF %N&lt; PREP
13	}	}
14	3	3		@QN&gt; %&gt;N NUM CARD	@A&gt; %&gt;N NUM CARD	@ADVL %EH NUM CARD
15	bp	bp		@SUBJ %NH ABBR NOM SG	@&lt;P %NH ABBR NOM SG	@&lt;NOM %N&lt; ABBR NOM SG	@ADVL %EH ABBR NOM SG
16	,	,
17	as	as		@CS %CS CS
18	can	can	v-ch:&gt;19	@+FAUXV %AUX V AUXMOD
19	occur	occur		@-FMAINV %VA V INF
20	for	for	ha:&gt;19	@ADVL %EH PREP
21	natural	natural	attr:&gt;22	@A&gt; %&gt;N A ABS
22	SRE	sre	subj:&gt;23	@SUBJ %NH N NOM SG
23	sequences	sequence		@+FMAINV %VA V PRES SG3
24	,	,
25	while	while	tmp:&gt;30	@ADVL %EH ADV WH
26	a	a	det:&gt;28	@DN&gt; %&gt;N DET SG
27	smaller	small	attr:&gt;28	@A&gt; %&gt;N A CMP
28	spacing	spacing	subj:&gt;29	@SUBJ %NH N NOM SG
29	would	would	v-ch:&gt;30	@+FAUXV %AUX V AUXMOD
30	inhibit	inhibit	tmp:&gt;23	@-FMAINV %VA V INF
31	the	the	det:&gt;33	@DN&gt; %&gt;N DET
32	simultaneous	simultaneous	attr:&gt;33	@A&gt; %&gt;N A ABS
33	binding	binding	obj:&gt;30	@OBJ %NH N NOM SG
34	of	of	mod:&gt;33	@&lt;NOM-OF %N&lt; PREP
35	both	both	det:&gt;36	@DN&gt; %&gt;N DET PL
36	proteins	protein	pcomp:&gt;34	@&lt;P %NH N NOM PL
37	.     .
</fdg>
</example>
<example src="EMBO" no="3">
<text>
It was reported that GPI anchoring ability was lost when the microsomal membranes of Trypanosoma brucei were washed at high pH (Sharma et al., 2000), whereas similar treatment of the mammalian microsomal membranes had no effect (Vidugiriene and Menon, 1995)

</text>
       <arg n="0">-
</arg>
       <arg n="1">GPI anchoring ability
</arg>
       <arg n="2">when the microsomal membranes of Trypanosoma brucei were washed at high pH
</arg>
<fdg>
1	It	it	subj:&gt;2	@SUBJ %NH PRON NOM SG3
2	was	be	v-ch:&gt;3	@+FAUXV %AUX V PAST
3	reported	report	main:&gt;0	@-FMAINV %VP EN
4	that	that	pm:&gt;9	@CS %CS CS
5	GPI	gpi	subj:&gt;8	@SUBJ %NH ABBR NOM SG
6	anchoring	anchor	mod:&gt;5	@-FMAINV %VA ING
7	ability	ability	obj:&gt;6	@OBJ %NH N NOM SG
8	was	be	v-ch:&gt;9	@+FAUXV %AUX V PAST
9	lost	lose	obj:&gt;3	@-FMAINV %VP EN
10	when	when	tmp:&gt;18	@ADVL %EH ADV WH
11	the	the	det:&gt;13	@DN&gt; %&gt;N DET
12	microsomal	microsomal	attr:&gt;13	@A&gt; %&gt;N &lt;?&gt; A ABS
13	membranes	membrane	subj:&gt;17	@SUBJ %NH N NOM PL
14	of	of	mod:&gt;13	@&lt;NOM-OF %N&lt; PREP
15	Trypanosoma	trypanosoma	attr:&gt;16	@A&gt; %&gt;N &lt;?&gt; N NOM SG
16	brucei	brucei	pcomp:&gt;14	@&lt;P %NH &lt;?&gt; N NOM SG
17	were	be	v-ch:&gt;18	@+FAUXV %AUX V PAST PL
18	washed	wash	obj:&gt;9	@-FMAINV %VP EN
19	at	at	ha:&gt;18	@ADVL %EH PREP
20	high	high	attr:&gt;21	@A&gt; %&gt;N A ABS
21	pH	ph	pcomp:&gt;19	@&lt;P %NH ABBR NOM SG
22	(	(
23	Sharma	sharma	main:&gt;22	@APP %NH N NOM SG
24	et	et		@CC %CC CC
25	al.	al.		@APP %NH ABBR NOM SG	@A&gt; %&gt;N ABBR NOM SG	@&lt;P %NH ABBR NOM SG	@NH %NH ABBR NOM SG	@&lt;NOM %N&lt; ABBR NOM SG	@ADVL %EH ABBR NOM SG
26	,	,
27	2000	2000		@NH %NH NUM CARD	@&lt;P %NH NUM CARD	@A&gt; %&gt;N NUM CARD	@&lt;NOM %N&lt; NUM CARD	@ADVL %EH NUM CARD
28	)	)
29	,	,
30	whereas	whereas	pm:&gt;38	@CS %CS CS
31	similar	similar	attr:&gt;32	@A&gt; %&gt;N A ABS
32	treatment	treatment	subj:&gt;38	@SUBJ %NH N NOM SG
33	of	of	mod:&gt;32	@&lt;NOM-OF %N&lt; PREP
34	the	the	det:&gt;37	@DN&gt; %&gt;N DET
35	mammalian	mammalian	attr:&gt;36	@A&gt; %&gt;N A ABS
36	microsomal	microsomal	attr:&gt;37	@A&gt; %&gt;N &lt;?&gt; A ABS
37	membranes	membrane	pcomp:&gt;33	@&lt;P %NH N NOM PL
38	had	have	cnd:&gt;18	@+FMAINV %VA V PAST
39	no	no	det:&gt;40	@DN&gt; %&gt;N DET
40	effect	effect	obj:&gt;38	@OBJ %NH N NOM SG
41	(	(
42	Vidugiriene	vidugiriene	main:&gt;41	@APP %NH &lt;?&gt; N NOM SG
43	and	and		@CC %CC CC
44	Menon	menon		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@OBJ %NH N NOM SG	@PCOMPL-S %NH N NOM SG	@APP %NH N NOM SG	@A&gt; %&gt;N N NOM SG
45	,	,
46	1995	1995		@NH %NH NUM CARD	@SUBJ %NH NUM CARD	@OBJ %NH NUM CARD	@PCOMPL-S %NH NUM CARD	@PCOMPL-O %NH NUM CARD	@&lt;P %NH NUM CARD	@A&gt; %&gt;N NUM CARD	@&lt;NOM %N&lt; NUM CARD	@ADVL %EH NUM CARD
47	)	)
48	.     .
</fdg>
</example>
<example src="EMBO" no="4">
<text>
No known plastid has completely lost its prokaryote-type organelle genome, but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (Martin and Hrrmann, 1998).

</text>
       <arg n="0">No known plastid
</arg>
       <arg n="1">its prokaryote-type organelle genome
</arg>
       <arg n="2">-
</arg>
<fdg>
1	No	no	det:&gt;3	@DN&gt; %&gt;N DET
2	known	known	attr:&gt;3	@A&gt; %&gt;N A ABS
3	plastid	plastid	subj:&gt;4	@SUBJ %NH &lt;?&gt; N NOM SG
4	has	have	v-ch:&gt;6	@+FAUXV %AUX V PRES SG3
5	completely	completely	meta:&gt;6	@ADVL %EH ADV
6	lost	lose		@-FMAINV %VA EN
7	its	it	attr:&gt;8	@A&gt; %&gt;N PRON GEN SG3
8	prokaryote	prokaryote	obj:&gt;6	@OBJ %NH N NOM SG
9	-	-
10	type	type		@+FMAINV %VA V PRES	@-FMAINV %VA V INF	@&lt;P-FMAINV %VA V INF
11	organelle	organelle	attr:&gt;12	@A&gt; %&gt;N N NOM SG
12	genome	genome	obj:&gt;10	@OBJ %NH N NOM SG
13	,	,
14	but	but		@CC %CC CC
15	all	all	det:&gt;16	@DN&gt; %&gt;N DET
16	show	show		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@OBJ %NH N NOM SG
17	considerable	considerable	attr:&gt;18	@A&gt; %&gt;N A ABS
18	genome	genome	attr:&gt;19	@A&gt; %&gt;N N NOM SG
19	reduction	reduction		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@OBJ %NH N NOM SG	@APP %NH N NOM SG
20	and	and		@CC %CC CC
21	dependency	dependency		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@OBJ %NH N NOM SG	@APP %NH N NOM SG
22	on	on	mod:&gt;21	@&lt;NOM %N&lt; PREP
23	the	the	det:&gt;24	@DN&gt; %&gt;N DET
24	nucleus	nucleus	pcomp:&gt;22	@&lt;P %NH N NOM SG
25	to	to	pm:&gt;26	@INFMARK&gt; %AUX INFMARK&gt;
26	fulfill	fulfill	mod:&gt;24	@-FMAINV %VA V INF
27	plastid	plastid	attr:&gt;28	@A&gt; %&gt;N &lt;?&gt; N NOM SG
28	functions	function	obj:&gt;26	@OBJ %NH N NOM PL
29	(	(
30	Martin	martin	main:&gt;29	@APP %NH N NOM SG
31	and	and		@CC %CC CC
32	Herrmann	herrmann		@NH %NH N NOM SG	@APP %NH N NOM SG	@A&gt; %&gt;N N NOM SG
33	,	,
34	1998	1998		@NH %NH NUM CARD	@A&gt; %&gt;N NUM CARD	@&lt;NOM %N&lt; NUM CARD	@ADVL %EH NUM CARD
35	)	)
36	.     .
</fdg>
</example>
<example src="EMBO" no="5">
<text>
Previous studies have emphasized the high sensitivity of the N-terminal region to proteolytic cleavage, leading to truncated species that have lost the first 20&amp;#8211; 70 residues but that retain enzymatic activity and dimeric structure.

</text>
       <arg n="0">truncated species
</arg>
       <arg n="1">the first 20&amp;#8211; 70 residues
</arg>
       <arg n="2">-
</arg>
<fdg>
1	Previous	previous	attr:&gt;2	@A&gt; %&gt;N A ABS
2	studies	study	subj:&gt;3	@SUBJ %NH N NOM PL
3	have	have	v-ch:&gt;4	@+FAUXV %AUX V PRES
4	emphasized	emphasize	main:&gt;0	@-FMAINV %VA EN
5	the	the	det:&gt;7	@DN&gt; %&gt;N DET
6	high	high	attr:&gt;7	@A&gt; %&gt;N A ABS
7	sensitivity	sensitivity	obj:&gt;4	@OBJ %NH N NOM SG
8	of	of	mod:&gt;7	@&lt;NOM-OF %N&lt; PREP
9	the	the	det:&gt;11	@DN&gt; %&gt;N DET
10	N-terminal	n-terminal	attr:&gt;11	@A&gt; %&gt;N A ABS
11	region	region	pcomp:&gt;8	@&lt;P %NH N NOM SG
12	to	to		@&lt;NOM %N&lt; PREP	@ADVL %EH PREP
13	proteolytic	proteolytic	attr:&gt;14	@A&gt; %&gt;N A ABS
14	cleavage	cleavage	pcomp:&gt;12	@&lt;P %NH N NOM SG
15	,	,
16	leading	lead	ha:&gt;4	@-FMAINV %VA ING
17	to	to	ha:&gt;16	@ADVL %EH PREP
18	truncated	truncated	attr:&gt;19	@A&gt; %&gt;N A ABS
19	species	species	pcomp:&gt;17	@&lt;P %NH N NOM
20	that	that	subj:&gt;21	@SUBJ %NH &lt;Rel&gt; PRON
21	have	have	v-ch:&gt;22	@+FAUXV %AUX V PRES
22	lost	lose	mod:&gt;19	@-FMAINV %VA EN
23	the	the	det:&gt;26	@DN&gt; %&gt;N DET
24	first	first	attr:&gt;25	@A&gt; %&gt;N NUM ORD
25	20	20	qn:&gt;26	@QN&gt; %&gt;N NUM CARD
26	&amp;#8211;	&amp;#8211;	obj:&gt;22	@OBJ %NH N NOM SG
27	70	70	qn:&gt;28	@QN&gt; %&gt;N NUM CARD
28	residues	residue		@SUBJ %NH N NOM PL	@OBJ %NH N NOM PL
29	but	but	cc:&gt;22	@CC %CC CC
30	that	that	subj:&gt;31	@SUBJ %NH &lt;Rel&gt; PRON
31	retain	retain	cc:&gt;22	@+FMAINV %VA V PRES
32	enzymatic	enzymatic	attr:&gt;33	@A&gt; %&gt;N A ABS
33	activity	activity	obj:&gt;31	@OBJ %NH N NOM SG
34	and	and	cc:&gt;33	@CC %CC CC
35	dimeric	dimeric	attr:&gt;36	@A&gt; %&gt;N &lt;?&gt; A ABS
36	structure	structure	cc:&gt;33	@OBJ %NH N NOM SG
37	.     .
</fdg>
</example>
<example src="EMBO" no="6">
<text>
The C-terminal-deletion mutant of hnRNP A1 loses the ability to interact with the X protein and to bring it into the initiation complex, resulting in and inhibition of MHV RNA transcription and replication.

</text>
       <arg n="0">The C-terminal-deletion mutant of hnRNP A1
</arg>
       <arg n="1">the ability to interact with the X protein and to bring it into the initiation complex
</arg>
       <arg n="2">-
</arg>
<fdg>
1	The	the	det:&gt;3	@DN&gt; %&gt;N DET
2	C-terminal-deletion	c-terminal-deletion	attr:&gt;3	@A&gt; %&gt;N N NOM SG
3	mutant	mutant	subj:&gt;7	@SUBJ %NH N NOM SG
4	of	of	mod:&gt;3	@&lt;NOM-OF %N&lt; PREP
5	hnRNP	hnrnp	attr:&gt;6	@A&gt; %&gt;N &lt;?&gt; N NOM SG
6	A1	a1	pcomp:&gt;4	@&lt;P %NH ABBR NOM SG
7	loses	lose	main:&gt;0	@+FMAINV %VA V PRES SG3
8	the	the	det:&gt;9	@DN&gt; %&gt;N DET
9	ability	ability	obj:&gt;7	@OBJ %NH N NOM SG
10	to	to	pm:&gt;11	@INFMARK&gt; %AUX INFMARK&gt;
11	interact	interact	mod:&gt;9	@-FMAINV %VA V INF
12	with	with	phr:&gt;11	@ADVL %EH PREP
13	the	the	det:&gt;15	@DN&gt; %&gt;N DET
14	X	x	attr:&gt;15	@A&gt; %&gt;N NUM ORD
15	protein	protein	pcomp:&gt;12	@&lt;P %NH N NOM SG
16	and	and	cc:&gt;11	@CC %CC CC
17	to	to	pm:&gt;18	@INFMARK&gt; %AUX INFMARK&gt;
18	bring	bring	cc:&gt;11	@-FMAINV %VA V INF
19	it	it	obj:&gt;18	@OBJ %NH PRON ACC SG3
20	into	into	goa:&gt;18	@ADVL %EH PREP
21	the	the	det:&gt;23	@DN&gt; %&gt;N DET
22	initiation	initiation	attr:&gt;23	@A&gt; %&gt;N N NOM SG
23	complex	complex	pcomp:&gt;20	@&lt;P %NH A ABS
24	,	,
25	resulting	result		@-FMAINV %VA ING
26	in	in	loc:&gt;25	@ADVL %EH PREP
27	an	an	det:&gt;28	@DN&gt; %&gt;N DET SG
28	inhibition	inhibition	pcomp:&gt;26	@&lt;P %NH N NOM SG
29	of	of	mod:&gt;28	@&lt;NOM-OF %N&lt; PREP
30	MHV	mhv	attr:&gt;31	@A&gt; %&gt;N N NOM SG
31	RNA	rna	attr:&gt;32	@A&gt; %&gt;N ABBR NOM SG
32	transcription	transcription	pcomp:&gt;29	@&lt;P %NH N NOM SG
33	and	and	cc:&gt;32	@CC %CC CC
34	replication	replication	cc:&gt;32	@&lt;P %NH N NOM SG
35	.     .
</fdg>
</example>
</roleset>
</predicate>
</frameset>
